Top Markets
Coin of the day
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
Rank in Stocks #39157
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Share Price
$0.995
Last synced: 2023-07-07
Market Cap
$624.98K
Change (1 day)
-0.50%
Change (1 year)
0.00%
Country
US
Trade H-CYTE, Inc. (HCYT)

Category

Dividend yield history for H-CYTE, Inc. (HCYT)
H-CYTE, Inc. (stock symbol: HCYT) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for H-CYTE, Inc. (HCYT) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors